Newsletters and Deep Dive digital magazine
Drug successful in late stage trial for giant cell arteritis
Midostaurin also under review in rare disease systemic mastocytosis
Shingrix has blockbuster potential, according to analysts.
Reforms will make applications streamlined and flexible without affecting safety, says agency.
An inside guide to unlocking clinical research in the UK